Literature DB >> 9169490

Transcriptional control in keratinocytes and fibroblasts using synthetic ligands.

R A Freiberg1, S N Ho, P A Khavari.   

Abstract

The skin is an attractive tissue for regulated target gene expression by virtue of its accessibility to topical regulating stimuli. We have used synthetic ligand-driven intracellular oligomerization to accomplish specific target gene regulation in human skin keratinocytes and fibroblasts. GAL4 DNA binding domains and VP16 transactivation domains, each linked to the FK506 binding protein, were expressed in normal human skin keratinocytes and fibroblasts. These hybrid proteins underwent heterodimerization via the novel intracellular dimerizing agent FK1012 to generate a heterodimeric activator of target gene expression in vitro. Dimeric FK1012, but not monomeric FK506M induced target gene expression in a dose-dependent fashion. FK1012 exerted no detectable nonspecific effects on expression of cutaneous genes and did not alter cellular proliferation kinetics. Controlled oligomerization of hybrid transcription activators offers a potential approach to target gene regulation in cells of normal human skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169490      PMCID: PMC508106          DOI: 10.1172/JCI119449

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy.

Authors:  E S Fenjves; D A Gordon; L K Pershing; D L Williams; L B Taichman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper.

Authors:  R Schüle; R M Evans
Journal:  Trends Genet       Date:  1991 Nov-Dec       Impact factor: 11.639

3.  Comparison of methods for transfection of human epidermal keratinocytes.

Authors:  C K Jiang; D Connolly; M Blumenberg
Journal:  J Invest Dermatol       Date:  1991-12       Impact factor: 8.551

4.  Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity.

Authors:  T K Kerppola; T Curran
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

5.  Dimeric ligands define a role for transcriptional activation domains in reinitiation.

Authors:  S N Ho; S R Biggar; D M Spencer; S L Schreiber; G R Crabtree
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

6.  T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction.

Authors:  H L Chang; M H Zaroukian; W J Esselman
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

7.  Functional comparison of the upstream regulatory DNA sequences of four human epidermal keratin genes.

Authors:  C K Jiang; H S Epstein; M Tomic; I M Freedberg; M Blumenberg
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

8.  Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.

Authors:  D S Anson; J Bielicki; J J Hopwood
Journal:  Hum Gene Ther       Date:  1992-08       Impact factor: 5.695

9.  Glucocorticoid and retinoid regulation of alpha-2 type I procollagen promoter activity.

Authors:  J R Perez; S Shull; G J Gendimenico; R J Capetola; J A Mezick; K R Cutroneo
Journal:  J Cell Biochem       Date:  1992-09       Impact factor: 4.429

10.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.

Authors:  J G Rheinwald; H Green
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

View more
  1 in total

1.  Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.

Authors:  Susana Ortiz-Urda; Qun Lin; Cheryl L Green; Douglas R Keene; M Peter Marinkovich; Paul A Khavari
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.